Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Assets Average (2016 - 2025)

Historic Assets Average for Heron Therapeutics (HRTX) over the last 13 years, with Q3 2025 value amounting to $240.5 million.

  • Heron Therapeutics' Assets Average rose 959.8% to $240.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.5 million, marking a year-over-year increase of 959.8%. This contributed to the annual value of $227.8 million for FY2024, which is 376.04% down from last year.
  • Latest data reveals that Heron Therapeutics reported Assets Average of $240.5 million as of Q3 2025, which was up 959.8% from $233.9 million recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Assets Average ranged from a high of $378.3 million in Q3 2021 and a low of $211.1 million during Q2 2023
  • In the last 5 years, Heron Therapeutics' Assets Average had a median value of $235.9 million in 2023 and averaged $260.4 million.
  • Per our database at Business Quant, Heron Therapeutics' Assets Average tumbled by 3299.66% in 2021 and then surged by 959.8% in 2025.
  • Over the past 5 years, Heron Therapeutics' Assets Average (Quarter) stood at $329.0 million in 2021, then dropped by 20.54% to $261.5 million in 2022, then fell by 13.62% to $225.9 million in 2023, then grew by 0.49% to $227.0 million in 2024, then rose by 5.97% to $240.5 million in 2025.
  • Its Assets Average stands at $240.5 million for Q3 2025, versus $233.9 million for Q2 2025 and $234.4 million for Q1 2025.